Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting Nanotech Investing
MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29 Nanotech Investing
Nuvation Bio Announces IBTROZI® Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026 Nanotech Investing
Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting Nanotech Investing
Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib's Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer Nanotech Investing
Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026 Nanotech Investing
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics Nanotech Investing
PRAME-directed Cell Therapy Using Immatics' TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma Nanotech Investing
Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board Technology Investing
Folia Health Launches "BRAVE-PWS" Study to Better Understand the Real-World Experience of Prader-Willi Syndrome Caregivers Nanotech Investing
